This is going to sound dumb….. but

Hey everyone,

I have a silly question. I joined this group ages ago, as my husband
is a Type 2 diabetic. Well, he is on Byetta and has been for some
time now. He is SO lax these days with it I could strangle him, but
that is for another post! I have a question.

Where did you find information about Byetta being a Gila Monster spit
derivative? I am currently taking a Pharmacology course for my
nursing classes, and we have been discussing diabetic medications.
Byetta, or anything like it was not mentioned. So, I planned on
taking in my Byetta knowledge and WOWING the teacher.

However, I am at a loss as to where on the net I can find information
on how Byetta came to be. Can anyone help me? I’d so appreciate it.

I know I have heard from others that it is ‘lizard spit’, but I cant
seem to find any facts to back that up.

Thanks so much in advance for your help. I would really appreciate it!

Andi

2 Responses to “This is going to sound dumb….. but”

  1. Traci Mcgee Says:

    Andi,
    This is from MyDiabetesCentral.com . I hope this helps. I may have posted it
    to the group before. If so my apologies. But, it is interesting reading none
    the less. He has other interesting stuff worth browsing.
    Pam

    That’s the conventional wisdom. Yet just one person, Dr. John Eng, is
    responsible for the discovery of Byetta. The Food and Drug Administration
    approved this powerful new diabetes medication on April 29, 2005.

    One of those giants was Dr. Eng’s mentor, Dr. Rosalyn S. Yalow, who won the 1977
    Nobel Prize in Medicine for the development of radioimmunoassays of peptide
    hormones. After becoming an endocrinologist, Dr. Eng wanted to do endocrine
    research and worked in her lab at the VA Medical Center in New York for 18 years
    until she retired.

    "The first hormones that were discovered were those in the greatest abundance,
    like insulin," he said. "In research we always want to find something new, and I
    am no exception."

    He thought that there might still be hormones out there waiting to be
    discovered. Radioimmunoassays couldn’t help Dr. Eng find them, because those
    assays aren’t a good way to discover new hormones. But there were other
    shoulders for Dr. Eng to stand on.

    So Dr. Eng decided to use chemical assays to look for the new hormones that he
    thought were out there and that he so much wanted to find. But where to look?

    He found a sequence never before described. One of his responsibilities to
    science then was to name it. Since it is an EXocrine secretion that has an
    ENDocrINe function, he named it exendin.

    Then Dr. Eng had to show that exendin had biological activity. "Otherwise, it’s
    just another peptide."

    But GLP-1 itself breaks down in a matter of minutes, so the only way that we
    could use it would be by a continuous infusion drip. Not fun.

    The form of exendin that Dr. Eng synthesized from the Gila monster, however,
    stays in our bloodstream for hours. It then became clear to Dr. Eng that it
    could be a valuable medication for people with diabetes.

    So he tried to get the Veterans Administration, where he has spent his entire
    career, to patent his invention. But at that time the VA was only interested in
    patenting inventions that were specific to veterans, like spinal cord injury,
    loss of limbs, or prostheses.

    "That put me in a difficult position," he told me, "because it meant I had to
    essentially make a bet. Patenting it came out of my pocket with no guarantee
    that anything would come of it."

    All along the way the Byetta story has been full of ironies. One of the first
    was the fact that while Lilly turned down the chance to develop Byetta alone, it
    was the company that Amylin turned to in order to jointly market it.

    Another is that Dr. Eng had never seen a Gila monster when he invented Byetta.
    It was only a year or two ago that he finally got to see one, he told me when we
    talked again this week. He was in a film about Gila monsters made by a wildlife
    expert in England that U.S. public television showed.

    One of the strangest ironies is that none of Dr. Eng’s research articles or his
    patent on extendin even mention the weight loss that it often leads to. I asked
    him this week when he first realized that it could lead to weight loss.

    "I didn’t," he replied. It was only in the Amylin’s Phase 3 trials that the
    weight loss became apparent.

    Finally, Dr. Eng told me that he hasn’t been able to prescribe Byetta. He can’t,
    because it isn’t in the VA formulary. "That’s ironic," he says.

    You may also be interested in:

    Comments

    That’s the conventional wisdom. Yet just one person, Dr. John Eng, is
    responsible for the discovery of Byetta. The Food and Drug Administration
    approved this powerful new diabetes medication on April 29, 2005.

    One of those giants was Dr. Eng’s mentor, Dr. Rosalyn S. Yalow, who won the 1977
    Nobel Prize in Medicine for the development of radioimmunoassays of peptide
    hormones. After becoming an endocrinologist, Dr. Eng wanted to do endocrine
    research and worked in her lab at the VA Medical Center in New York for 18 years
    until she retired.

    "The first hormones that were discovered were those in the greatest abundance,
    like insulin," he said. "In research we always want to find something new, and I
    am no exception."

    He thought that there might still be hormones out there waiting to be
    discovered. Radioimmunoassays couldn’t help Dr. Eng find them, because those
    assays aren’t a good way to discover new hormones. But there were other
    shoulders for Dr. Eng to stand on.

    So Dr. Eng decided to use chemical assays to look for the new hormones that he
    thought were out there and that he so much wanted to find. But where to look?

    He found a sequence never before described. One of his responsibilities to
    science then was to name it. Since it is an EXocrine secretion that has an
    ENDocrINe function, he named it exendin.

    Then Dr. Eng had to show that exendin had biological activity. "Otherwise, it’s
    just another peptide."

    But GLP-1 itself breaks down in a matter of minutes, so the only way that we
    could use it would be by a continuous infusion drip. Not fun.

    The form of exendin that Dr. Eng synthesized from the Gila monster, however,
    stays in our bloodstream for hours. It then became clear to Dr. Eng that it
    could be a valuable medication for people with diabetes.

    So he tried to get the Veterans Administration, where he has spent his entire
    career, to patent his invention. But at that time the VA was only interested in
    patenting inventions that were specific to veterans, like spinal cord injury,
    loss of limbs, or prostheses.

    "That put me in a difficult position," he told me, "because it meant I had to
    essentially make a bet. Patenting it came out of my pocket with no guarantee
    that anything would come of it."

    All along the way the Byetta story has been full of ironies. One of the first
    was the fact that while Lilly turned down the chance to develop Byetta alone, it
    was the company that Amylin turned to in order to jointly market it.

    Another is that Dr. Eng had never seen a Gila monster when he invented Byetta.
    It was only a year or two ago that he finally got to see one, he told me when we
    talked again this week. He was in a film about Gila monsters made by a wildlife
    expert in England that U.S. public television showed.

    One of the strangest ironies is that none of Dr. Eng’s research articles or his
    patent on extendin even mention the weight loss that it often leads to. I asked
    him this week when he first realized that it could lead to weight loss.

    "I didn’t," he replied. It was only in the Amylin’s Phase 3 trials that the
    weight loss became apparent.

    Finally, Dr. Eng told me that he hasn’t been able to prescribe Byetta. He can’t,
    because it isn’t in the VA formulary. "That’s ironic," he says.

    You may also be interested in:

    Comments

    Hey everyone,

    I have a silly question. I joined this group ages ago, as my husband
    is a Type 2 diabetic. Well, he is on Byetta and has been for some
    time now. He is SO lax these days with it I could strangle him, but
    that is for another post! I have a question.

    Where did you find information about Byetta being a Gila Monster spit
    derivative? I am currently taking a Pharmacology course for my
    nursing classes, and we have been discussing diabetic medications.
    Byetta, or anything like it was not mentioned. So, I planned on
    taking in my Byetta knowledge and WOWING the teacher.

    However, I am at a loss as to where on the net I can find information
    on how Byetta came to be. Can anyone help me? I’d so appreciate it.
    I know I have heard from others that it is ‘lizard spit’, but I cant
    seem to find any facts to back that up.

    Thanks so much in advance for your help. I would really appreciate it!

    Andi

  2. Ila Workman Says:

    I’m on digest, and I’m behind, so forgive me if someone’s already
    said this, but you can find the "history of byetta" at the byetta
    website.

    Sarah in TX

Leave a Reply

You must be logged in to post a comment.